No NHS Coverage for Janssen’s Spravato: NICE Denies Re-Appraisal of Esketamine for TRD

Finance

Reading Time: < 1 minute

Earlier this month, the National Institute for Health and Care Excellence (NICE), which stipulates which medical interventions are covered by England and Wales’ National Health Service (NHS), issued a statement that effectively brings Janssen’s ambitions to have its esketamine nasal spray (Spravato) product for treatment-resistant depression (TRD) reimbursed by the NHS in the UK’s most populous…
Source

Source link

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Email
This field is for validation purposes and should be left unchanged.

Subscribe to receive the latest business and industry news in your inbox.

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Email
This field is for validation purposes and should be left unchanged.

latest from the industry

PSYCHEDELICS news

Curtin University, Draslovka partner to advance glycine leaching technology

Reading Time: < 1 minute“The non-toxic amino acid has the potential to replace hazardous chemicals like cyanide in mineral

November 23, 2024

Psychedelic Santa Cruz – Using Psychedelics Daily for a happy & healthy life

Reading Time: < 1 minuteOur mission is to create community surrounding psychedelics, mental health, and spiritual growth. We’ll be

November 22, 2024

How to Process Payments for Your Cannabis Dispensary

Reading Time: 4 minutesHow to Process Payments for Your Cannabis Dispensary Cannabis dispensaries are becoming more common as